fda warning letters compounded tirzepatide 2024 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Thinking about buying GLP-1 and
Description
semaglutide for weight loss, is one better
You might conclude that tirzepatide "does not work for me" when the reality is that you never reached a therapeutic dose
10.2337/dc11-s231 16 GarveyW
Your doctor screens for all of this before prescribing
Compounded drug products are not FDA-approved.Required Actions: Within 15 days, the company must respond in writing to the Office of Compounding Quality and Compliance (OCQC) with a description of how the company has addressed the violations, including removal of misleading language
And i havent gone up in doses yet
